🇺🇸 FDA
Pipeline program

VAXIGRIPTETRA, suspension injectable en seringue préremplie Vaccin grippal quadrivalent (inactivé, à virion fragmenté)

IVAMI

Phase 2 small_molecule active

Quick answer

VAXIGRIPTETRA, suspension injectable en seringue préremplie Vaccin grippal quadrivalent (inactivé, à virion fragmenté) for patients with stable coronary artery disease is a Phase 2 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).

Program details

Company
Tour Hekla
Indication
patients with stable coronary artery disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials